Within the TME, DCs present major histocompatibility complex (MHC) molecules on tumor-associated antigens and provide co-stimulatory molecules and soluble factors to attract and mediate the activation and function of anti-tumor T cells [73]. This evidence concerns the gene HLA-C and neoplasm.